Search Technologies
Displaying 1 - 2 of 2 results
Researchers at the University of Maryland have created hundreds of innovations that are available for licensing. Our Discovery Portfolio contains an exciting mix of vaccines, drug targets, therapeutics, devices and cutting edge techniques that promise to make a quantifiable impact on human health and the environment.
Search by keyword:
-
Repurposed drugs for Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Published Monday, November 24, 2014Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS) are viral respiratory diseases caused by novel coronavirus strains (SARS-CoV and MERS-CoV, respectively). Categorized as a select agent in 2012, approximately 9,000 cases of SARS have been reported, with 9.5% mortality rate. To date, there have been 1,917...
Investigator(s): Mathew Frieman, Lisa Hensley, Peter Jahrling
Categories: Therapeutics, Small molecules, Chemicals, Repurpose Drug
Keyword(s): MERS, SARS, Repurposed drugs, antiviral drugs
Docket: MF-2014-090
-
New Treatments for Viral Diseases
Published Thursday, March 6, 2008Human viral epidemics have proliferated since the latter half of the 20th century. The same cannot be said of the medicines used to treat them. As HIV spreads to nearly every corner of the world, existing antivirals cannot fill the global need for inexpensive, easily accessible forms of treatment. New and potentially helpful drugs face a long and...
Categories: Small molecules, Therapeutics, Repurpose Drug
Keyword(s): Viral therapy, antibiotic
Docket: LS-2007-092